FOXO4-DRI has a rapidly expanding and high-impact published research base, with studies published across Nature, Nature Communications, Communications Biology, Aging, Frontiers in Bioengineering and Biotechnology, and PMC since its foundational description in 2017
For someone struggling with life-altering low blood sugar this was really difficult
A study using Swedish and Danish national databases compared cancer incidence in over 20,000 GLP-1 users versus other diabetes medications and found no elevated risk for colon or rectal cancers during follow-up periods extending beyond three years
What type of program is Brightmeds GLP-1
A 68-week trial, no matter how impressive the results, does not replace years of real-world experience
There were increments with high significant differences in the mean from FVC and FEV 1 with MAHT 8mg